for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-EU approves Roche's Kadcyla in early breast cancer

Dec 19 (Reuters) - Roche Holding AG:

* EUROPEAN COMMISSION APPROVES ROCHE’S KADCYLA FOR THE ADJUVANT TREATMENT OF PEOPLE WITH HER2-POSITIVE EARLY BREAST CANCER WITH RESIDUAL INVASIVE DISEASE AFTER NEOADJUVANT TREATMENT Further company coverage: (Reporting by Silke Koltrowitz)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up